PDE4A and major depressive disorder: Given the potential CNS uses of PDE4-selective inhibitors, and the potential correlations between depressive disorders and cognitive and neurophysiological symptoms [58,59], we were particularly interested in testing the effect of PDE4D5-D556A on cognition, activity, learning and memory, and on measures of anxiety or depression.